Concepedia

Samuel S. Blumenthal

SS

Statistics

Publications

35

Citations

3.9K

H-Index

26

Active since

1985

Affiliations

Medical College of Wisconsin(Current)

University of Wisconsin–Milwaukee

Milwaukee VA Medical Center

Vanderbilt University Medical Center

Cleveland Clinic

Samuel S. Blumenthal is an author at Medical College of Wisconsin specializing in medicine, renal disease, and renal pathophysiology.

Publications per year

1985–2019

35

Publications

35

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

, , +10

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour et al. · New England Journal of Medicine · 2019 · 600 citations · Full text

, , +15

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial

Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier et al. · Journal of the American Society of Nephrology · 2005 · 374 citations

, , +17

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 273 citations

, , +17

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD

Gerald Schulman, Rajiv Agarwal, Muralidhar Acharya et al. · American Journal of Kidney Diseases · 2006 · 198 citations

, , +5

1–5 of 35